Clinical Focus ›› 2023, Vol. 38 ›› Issue (6): 550-553.doi: 10.3969/j.issn.1004-583X.2023.06.013
Previous Articles Next Articles
-
Received:2023-04-15Online:2023-06-20Published:2023-08-18
CLC Number:
Cite this article
share this article
Add to citation manager EndNote|Ris|BibTeX
URL: https://huicui.hebmu.edu.cn/EN/10.3969/j.issn.1004-583X.2023.06.013
| [1] | 中华医学会消化内镜学分会ERCP学组, 中国医师协会消化医师分会胆胰学组, 国家消化系统疾病临床医学研究中心. 中国ERCP指南(2018版)[J]. 中华消化内镜杂志, 2018, 35(11):777-813. |
| [2] |
Dumonceau JM, Kapral C, Aabakken L, et al. ERCP-related adverse events: European Society of Gastrointestinal Endoscopy (ESGE) Guideline[J]. Endoscopy, 2020, 52(2):127-149.
doi: 10.1055/a-1075-4080 URL |
| [3] |
Tryliskyy Y, Bryce GJ. Post-ERCP pancreatitis: Pathophysiology, early identification and risk stratification[J]. Adv Clin Exp Med. 2018, 27(1):149-154.
doi: 10.17219/acem/66773 pmid: 29521055 |
| [4] |
Han S, Attwell AR, Tatman P, et al. Adverse events associated with therapeutic endoscopic retrograde pancreatography[J]. Pancreas, 2021, 50(3):378-385.
doi: 10.1097/MPA.0000000000001769 URL |
| [5] |
Kato K, Shiba M, Kakiya Y, et al. Celecoxib oral administration for prevention of post-endoscopic retrograde cholangiopancreatography pancreatitis a randomized prospective trial[J]. Pancreas, 2017, 46(7):880-886.
doi: 10.1097/MPA.0000000000000852 URL |
| [6] |
Jang DK, Kim J, Paik CN, et al. Endoscopic retrograde cholangiopancreatography‐related adverse events in Korea: A nationwide assessment[J]. United European Gastroenterol J, 2022, 10(1): 73-79.
doi: 10.1002/ueg2.v10.1 URL |
| [7] |
Zhao ZH, Hu LH, Ren HB, et al. Incidence and risk factors for post-ERCP pancreatitis in chronic pancreatitis[J]. Gastrointest Endosc, 2017, 86(3): 519-524.e511.
doi: 10.1016/j.gie.2016.12.020 URL |
| [8] |
Freeman ML, Nelson DB, Sherman S, et al. Complications of endoscopic biliary sphincterotomy[J]. N Engl J Med, 1996, 335(13): 909-919.
doi: 10.1056/NEJM199609263351301 URL |
| [9] |
Sundaralingam P, Masson P, Bourke MJ. Early precut sphincterotomy does not increase risk during endoscopic retrograde cholangiopancreatography in patients with difficult biliary access: A meta-analysis of randomized controlled trials[J]. Clin Gastroenterol Hepatol, 2015, 13(10):1722-1729.
doi: 10.1016/j.cgh.2015.06.035 URL |
| [10] |
Fujita K, Yazumi S, Matsumoto H, et al. Multicenter prospective cohort study of adverse events associated with biliary endoscopic retrograde cholangiopancreatography: Incidence of adverse events and preventive measures for post-endoscopic retrograde cholangiopancreatography pancreatitis[J]. Dig Endosc, 2022, 34(6):1198-1204.
doi: 10.1111/den.v34.6 URL |
| [11] |
Cha SW, Leung WD, Lehman GA, et al. Does leaving a main pancreatic duct stent in place reduce the incidence of precut biliary sphincterotomy-associated pancreatitis? A randomized, prospective study[J]. Gastrointest Endosc, 2013, 77(2):209-216.
doi: 10.1016/j.gie.2012.08.022 URL |
| [12] |
Akshintala VS, Sperna Weiland CJ, Bhullar FA, et al. Non-steroidal anti-inflammatory drugs, intravenous fluids, pancreatic stents, or their combinations for the prevention of post-endoscopic retrograde cholangiopancreatography pancreatitis: A systematic review and network meta-analysis[J]. Lancet Gastroenterol Hepatol, 2021, 6(9):733-742.
doi: 10.1016/S2468-1253(21)00170-9 URL |
| [13] |
Sotoudehmanesh R, Ali-Asgari A, Khatibian M, et al. Pharmacological prophylaxis versus pancreatic duct stenting plus pharmacological prophylaxis for prevention of post-ERCP pancreatitis in high risk patients: a randomized trial[J]. Endoscopy, 2019, 51(10): 915-921.
doi: 10.1055/a-0977-3119 pmid: 31454851 |
| [14] |
Chandrasekhara V, Khashab MA, Muthusamy VR, et al. Adverse events associated with ERCP[J]. Gastrointest Endosc, 2017, 85(10): 32-47.
doi: 10.1016/j.gie.2016.06.051 URL |
| [15] |
Choi JH, Kim HJ, Lee BU, et al. Vigorous periprocedural hydration with lactated ringer’s solution reduces the risk of pancreatitis after retrograde cholangiopancreatography in hospitalized patients[J]. Clin Gastroenterol Hepatol, 2017, 15(1): 86-92.e1.
doi: 10.1016/j.cgh.2016.06.007 URL |
| [16] |
Elmunzer BJ, Scheiman JM, Lehman GA, et al. A randomized trial of rectal indomethacin to prevent post-ERCP pancreatitis[J]. N Engl J Med, 2012, 366(15): 1414-1422.
doi: 10.1056/NEJMoa1111103 URL |
| [17] |
Kubiliun NM, Adams MA, Akshintala VS, et al. Evaluation of pharmacologic prevention of pancreatitis after endoscopic retrograde cholangiopancreatography: A systematic review[J]. Clin Gastroenterol Hepatol, 2015, 13(7): 1231-1239.
doi: 10.1016/j.cgh.2014.11.038 URL |
| [18] |
Luo H, Zhao L, Leung J, et al. Routine pre-procedural rectal indometacin versus selective post-procedural rectal indometacin to prevent pancreatitis in patients undergoing endoscopic retrograde cholangiopancreatography: a multicentre, single-blinded, randomised controlled trial[J]. Lancet, 2016, 387(10035): 2293-2301.
doi: S0140-6736(16)30310-5 pmid: 27133971 |
| [19] |
Thiruvengadam NR, Forde KA, Ma GK, et al. Rectal indomethacin reduces pancreatitis in high-and low-risk patients undergoing endoscopic retrograde cholangiopancreatography[J]. Gastroenterology, 2016, 151(2): 288-297.e284.
doi: 10.1053/j.gastro.2016.04.048 pmid: 27215656 |
| [20] |
Dumonceau JM, Andriulli A, Elmunzer BJ, et al. Prophylaxis of post-ERCP pancreatitis: European Society of Gastrointestinal Endoscopy (ESGE) guideline-updated June 2014[J]. Endoscopy, 2014, 46(9): 799-815.
doi: 10.1055/s-00000012 URL |
| [21] |
Lyu Y, Wang B, Cheng Y, et al. Comparative efficacy of 9 major drugs for postendoscopic retrograde cholangiopancreatography pancreatitis: A network meta-analysis[J]. Surg Laparosc Endosc Percutan Tech, 2019, 29(6):426-432.
doi: 10.1097/SLE.0000000000000707 pmid: 31490455 |
| [22] |
Thiruvengadam NR, Forde KA, Chandrasekhara V, et al. Tacrolimus and indomethacin are safe and effective at reducing pancreatitis after endoscopic retrograde cholangiopancreatography in patients who have undergone liver transplantation[J]. Clin Gastroenterol Hepatol, 2020, 18(5):1224-1232.e1.
doi: 10.1016/j.cgh.2019.10.014 URL |
| [23] |
Wang G, Xiao G, Xu L, et al. Effect of somatostatin on prevention of post-endoscopic retrograde cholangiopancreatography pancreatitis and hyperamylasemia: A systematic review and meta-analysis[J]. Pancreatology, 2018, 18(4): 370-378.
doi: S1424-3903(18)30040-1 pmid: 29550097 |
| [24] |
Prachayakul V, Aswakul P. Endoscopic retrograde cholangiopancreatography-related perforation: management and prevention[J]. World J Clin Cases, 2014, 2(10):522-527.
doi: 10.12998/wjcc.v2.i10.522 pmid: 25325062 |
| [25] |
Artifon EL, Minata MK, Cunha MA, et al. Surgical or endoscopic management for post-ERCP large transmural duodenal perforations: A randomized prospective trial[J]. Rev Gastroenterol Peru, 2015, 35(4):313 -317.
pmid: 26802884 |
| [26] |
Weiser R, Pencovich N, Mlynarsky L, et al. Management of endoscopic retrograde cholangiopancreatography-related perforations: Experience of a tertiary center[J]. Surgery, 2017, 161(4):920-929.
doi: 10.1016/j.surg.2016.10.029 URL |
| [27] |
Cotton PB, Garrow DA, Gallagher J, et al. Risk factors for complications after ERCP: a multivariate analysis of 11, 497 procedures over 12 years[J]. Gastrointest Endosc, 2009, 70(1):80-88.
doi: 10.1016/j.gie.2008.10.039 pmid: 19286178 |
| [28] |
Jin YJ, Jeong S, Kim JH, et al. Clinical course and proposed treatment strategy for ERCP-related duodenal perforation: a multicenter analysis[J]. Endoscopy, 2013; 45(10):806 -812.
doi: 10.1055/s-00000012 URL |
| [29] |
Patil NS, Solanki N, Mishra PK, et al. ERCP-related perforation: an analysis of operative outcomes in a large series over 12 years[J]. Surg Endosc, 2020, 34(1):77 -87.
doi: 10.1007/s00464-019-06733-x |
| [30] | Niu F, Liu YD, Chen RX, et al. Safety and efficacy of enhanced recovery after surgery in elderly patients after therapeutic endoscopic retrograde cholangiopancreatography[J]. Wideochir Inne Tech Maloinwazyjne, 2019, 14(3):394-400. |
| [31] |
Theopistos V, Theocharis G, Konstantakis C, et al. Non-operative management of type 2 ERCP-related retroperitoneal duodenal perforations: A 9-year experience from a single center[J]. Gastroenterology Res, 2018, 11(3):207 -212.
doi: 10.14740/gr1007w URL |
| [32] |
Park TY, Bang CS, Choi SH, et al. Forward-viewing endoscope for ERCP in patients with Billroth II gastrectomy: A systematic review and meta-analysis[J]. Surg Endosc, 2018, 32(11):4598 -4613.
doi: 10.1007/s00464-018-6213-1 pmid: 29777352 |
| [33] |
Inamdar S, Berzin TM, Berkowitz J, et al. Decompensated cirrhosis may be a risk factor for adverse events in endoscopic retrograde cholangiopancreatography[J]. Liver Int, 2016, 36(10):1457 -1463.
doi: 10.1111/liv.13100 pmid: 26913829 |
| [34] |
Kim JY, Lee HS, Chung MJ, et al. Bleeding complications and clinical safety of endoscopic retrograde cholangiopancreatography in patients with liver cirrhosis[J]. Yonsei Med J, 2019, 60(5):440 -445.
doi: 10.3349/ymj.2019.60.5.440 pmid: 31016905 |
| [35] |
Johnson KD, Perisetti A, Tharian B, et al. Endoscopic retrograde cholangiopancreatography-related complications and their management strategies: A “Scoping” Literature Review[J]. Dig Dis Sci, 2020, 65(2):361 -375.
doi: 10.1007/s10620-019-05970-3 |
| [36] |
Li J, Li T, Sun P, et al. Covered versus uncovered self-expandable metal stents for managing malignant distal biliary obstruction: A meta-analysis[J]. PLoS One, 2016, 11(2):e0149066.
doi: 10.1371/journal.pone.0149066 URL |
| [37] |
Chen M, Wang L, Wang Y, et al. Risk factor analysis of post-ERCP cholangitis: A single-center experience[J]. Hepatobiliary Pancreat Dis Int, 2018, 17(1):55-58.
doi: 10.1016/j.hbpd.2018.01.002 URL |
| [38] | Du M, Suo J, Liu B, et al. Post-ERCP infection and its epidemiological and clinical characteristics in a large Chinese tertiary hospital: A 4-year surveillance study[J]. Antimicrob Resist Infect Control, 2017, 29(6):131 -136. |
| [39] |
Wobser H, Gunesch A, Klebl F. Prophylaxis of post-ERC infectious complications in patients with biliary obstruction by adding antimicrobial agents into ERC contrast media-a single center retrospective study[J]. BMC Gastroenterol, 2017, 17(1): 1-8.
doi: 10.1186/s12876-016-0563-8 URL |
| No related articles found! |
| Viewed | ||||||
|
Full text |
|
|||||
|
Abstract |
|
|||||